New publication in J Allergy Clin Immunol

Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments. The vaccine, which is still at the earliest research stage, has been tested on mice. The method can potentially also be used to develop different forms of vaccines, for example vaccines for autoimmune disorders.

Read the original publication:
Mathiesen CBK, Carlsson MC, Brand S, Möller SR, Idorn M, Straten PT, Pedersen AE, Dabelsteen S, Halim A, Würtzen PA, Brimnes J, Ipsen H, Petersen BL, Wandall HH (2018): Genetically engineered cell factories produce glycoengineered vaccines that target antigen presenting cells and reduce antigen specific T-cell reactivity. J Allergy Clin Immunol Aug 17. DOI: 10.1016/j.jaci.2018.07.030 (Epub ahead of print)

And UCPH Health News press release